3
Total deals
$446.3M
Total value
$223.2M
Avg deal
$275.3M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Mayne Pharma
Mayne Pharma Group, a specialist pharmaceutical company, optimizes and delivers …
|
2025-02-20 | Acquisition | Pending | $275.3M | Deal → |
| 2 |
Vyleesi
Vyleesi is an FDA-approved prescription treatment for premenopausal women with h…
|
2023-12-20 | Acquisition | Complete | $171.0M | Deal → |
| 3 |
Intrarosa
Intrarosa is a prescription medicine that contains both oestrogen and androgen a…
|
2023-06-08 | Acquisition | Complete | — | Deal → |